A phase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group Study S0605.

Source:http://linkedlifedata.com/resource/pubmed/id/21551228

Blood 2011 Jul 21 118 3 523-8

Download in:

View as

Triples

General Info

PMID
21551228